Assyro AI

Orange Book product · Brand (NDA)

TUZISTRA XR

CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX

Brand (NDA)NDA 207768DISCN TRIS PHARMA INC

At a glance

Apr 30, 2015

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 30, 2015

    11 yr 4 mo ago

  2. Today

  3. Patent 8790700 expires

    Listed drug product patent expiration.

    Mar 15, 2027

    in 9 mo

  4. Patent 8062667 expires

    Listed drug product patent expiration.

    Mar 29, 2029

    in 2 yr 10 mo

Pharmaceutical detail

Active ingredient

CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX

Strength

EQ 2.8MG BASE/5ML;EQ 14.7MG BASE/5ML

Dosage form

SUSPENSION, EXTENDED RELEASE

Route

ORAL

TE code

Not listed

Application

NDA 207768

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8790700Mar 15, 2027in 9 mo
Product
8062667Mar 29, 2029in 2 yr 10 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.